{
  "meta": {
    "title": "12_Depolarising_Muscle_Relaxants",
    "url": "https://brainandscalpel.vercel.app/12-depolarising-muscle-relaxants-ce40548a.html",
    "scrapedAt": "2025-11-30T12:25:42.834Z"
  },
  "questions": [
    {
      "text": "Which of the following statements is false regarding succinylcholine?",
      "choices": [
        {
          "id": 1,
          "text": "It produces both phase I and phase II block"
        },
        {
          "id": 2,
          "text": "It raises intracranial pressure"
        },
        {
          "id": 3,
          "text": "Precurarization reduces fasciculations and myalgia associated with Sch"
        },
        {
          "id": 4,
          "text": "It is a non–depolarizing muscle relaxant"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Succinylcholine</strong> is a <strong>depolarizing</strong> muscle relaxant.</p>\n<p>Option A: It produces both phase I and phase II block (at a higher dose).</p>\n<p>Option B: Succinylcholine can produce a rise in intracranial pressure as a result of increased cerebral blood flow due to muscle fasciculations.</p>\n<p>Option C:&nbsp;<strong>Precurarization</strong> is the administration of a <strong>small dose</strong>&nbsp;of a <strong>non-depolarizing</strong> neuromuscular blocking <strong>agent,</strong> a few minutes <strong>before Sch</strong> to <strong>minimize</strong>&nbsp;<strong>complications</strong> like fasciculations, post-operative myalgia, rise in intragastric pressure, and rise in ICP.</p><hr><h3>Related Pearl: Types of muscle relaxants</h3><p>There are 2 types of muscle relaxants: depolarizing and non-depolarizing.</p>\n<p><strong>Depolarizing</strong> Muscle Relaxant-<strong>&nbsp;Succinylcholine</strong></p>\n<p><strong>Non-Depolarizing</strong> Muscle Relaxants:</p>\n<ul>\n<li><strong>Ultra short-</strong>acting (&lt;10 minutes) - Gantacurium</li>\n<li><strong>Short</strong>-acting (10-20 minutes) -&nbsp;Mivacurium</li>\n<li><strong>Intermediate-</strong>acting (20-50 minutes)\n<ul>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Vecuronium</li>\n<li>Rocuronium</li>\n</ul>\n</li>\n<li><strong>Long-</strong>acting (&gt;50 minutes)\n<ul>\n<li>Pancuronium</li>\n<li>Doxacurium</li>\n<li>Pipecuronium</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3018",
      "difficulty": "easy"
    },
    {
      "text": "Which is the shortest acting muscle relaxant?",
      "choices": [
        {
          "id": 1,
          "text": "Vecuronium"
        },
        {
          "id": 2,
          "text": "Pancuronium"
        },
        {
          "id": 3,
          "text": "Suxamethonium"
        },
        {
          "id": 4,
          "text": "Pipecuronium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Suxamethonium</strong> (succinylcholine) is the shortest-acting muscle relaxant.</p>\n<p>It has a <strong>rapid-onset</strong> (30–60secs) and <strong>short duration</strong> of action (typically less than 10 min) due to <strong>rapid hydrolysis</strong> by butyrylcholinesterase (<strong>plasma cholinesterase</strong> or pseudocholinesterase).</p><hr><h3>Related Pearl: Types of muscle relaxants</h3><p>There are 2 types of muscle relaxants: depolarizing and non-depolarizing.</p>\n<p><strong>Depolarizing</strong> Muscle Relaxant-<strong>&nbsp;Succinylcholine</strong></p>\n<p><strong>Non-Depolarizing</strong> Muscle Relaxants:</p>\n<ul>\n<li><strong>Ultra short-</strong>acting (&lt;10 minutes) - Gantacurium</li>\n<li><strong>Short</strong>-acting (10-20 minutes) -&nbsp;Mivacurium</li>\n<li><strong>Intermediate-</strong>acting (20-50 minutes)\n<ul>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Vecuronium</li>\n<li>Rocuronium</li>\n</ul>\n</li>\n<li><strong>Long-</strong>acting (&gt;50 minutes)\n<ul>\n<li>Pancuronium</li>\n<li>Doxacurium</li>\n<li>Pipecuronium</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2978",
      "difficulty": "easy"
    },
    {
      "text": "In a road traffic accident victim with a GCS of 8/15, rapid sequence intubation is planned. Which of the following muscle relaxants is used here?",
      "choices": [
        {
          "id": 1,
          "text": "Atracurium"
        },
        {
          "id": 2,
          "text": "Mivacurium"
        },
        {
          "id": 3,
          "text": "Rocuronium"
        },
        {
          "id": 4,
          "text": "Succinylcholine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Succinylcholine</strong> is the muscle relaxant of choice for <strong>rapid sequence intubation. </strong>Although succinylcholine causes increase in ICP, it is used in rapid sequence intubation.</p>\n<p>Succinylcholine has a <strong>rapid onset</strong> of action and is the <strong>shortest acting</strong> muscle relaxant. It provides muscle relaxation within 30-60 seconds.</p>\n<p>If succinylcholine is <strong>contraindicated, </strong>then the non-depolarizing muscle relaxant,<strong> rocuronium </strong>can be used.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2980",
      "difficulty": "easy"
    },
    {
      "text": "Which drug produces phase II block?",
      "choices": [
        {
          "id": 1,
          "text": "Atracurium"
        },
        {
          "id": 2,
          "text": "Pancuronium"
        },
        {
          "id": 3,
          "text": "D-tubocurarine"
        },
        {
          "id": 4,
          "text": "Suxamethonium"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Suxamethonium</strong> (also known as succinylcholine) produces both <strong>phases I</strong> and <strong>II blocks.</strong></p>\n<p>Suxamethonium is a depolarizing muscle relaxant.</p>\n<p>Mechanism of depolarizing blockade:</p>\n<ul>\n<li>Phase I block - continuous endplate depolarization and subsequent muscle relaxation.</li>\n<li>Phase II block - seen with a <strong>single,</strong> <strong>large</strong> dose, <strong>repeated</strong> doses, or a <strong>continuous</strong> infusion which can lead to <strong>desensitization</strong> of the receptors resulting in the <strong>prolonged</strong> neuromuscular <strong>blockade.</strong></li>\n</ul>\n<p>Phase II block has features of a <strong>non-depolarizing blockade</strong>. But 'phase II' is specifically used for depolarizing blockade by succinylcholine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3019",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements regarding depolarising muscle relaxants is false?",
      "choices": [
        {
          "id": 1,
          "text": "Causes muscle fasciculations"
        },
        {
          "id": 2,
          "text": "Phase I block cannot be reversed by neostigmine"
        },
        {
          "id": 3,
          "text": "Depolarised muscle fibres are unresponsive to other stimuli"
        },
        {
          "id": 4,
          "text": "Fade is seen in phase I block"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Fade</strong> is seen in the non-depolarising <strong>phase II block</strong> caused by depolarizing muscle relaxants.</p>\n<p>Depolarising neuromuscular blockers result in <strong>prolonged depolarization</strong> with a brief period of <strong>fasciculations</strong> (repetitive excitation) followed by blocking of neuromuscular transmission and<strong> flaccid paralysis.&nbsp;</strong>This is termed as <strong>phase I&nbsp;block</strong> and can<strong>not</strong> be<strong> reversed</strong> by<strong> neostigmine</strong> as the membrane is in a depolarised state.</p>\n<p>The depolarised<strong> nerves</strong> are <strong>unresponsive</strong> to other stimuli during this period.</p>\n<p>As the concentration of the drug and time increases, the block may convert slowly to a non-depolarising phase II block. Fade&nbsp;can be seen in this phase. The phase II block is reversible by neostigmine but is difficult to predict and usually avoided in clinical conditions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0449",
      "difficulty": "medium"
    },
    {
      "text": "A 70 kg athlete was posted for surgery on her injured rotator cuff. She was administered a total of 640mg of succinylcholine by intermittent dosing. During recovery, she was unable to respire spontaneously and move her limbs. What is the most likely reason for this?",
      "choices": [
        {
          "id": 1,
          "text": "Muscular weakness due to fasciculation produced by succinylcholine"
        },
        {
          "id": 2,
          "text": "Undiagnosed muscular dystrophy and muscular weakness"
        },
        {
          "id": 3,
          "text": "Phase II blockade produced by succinyl choline"
        },
        {
          "id": 4,
          "text": "Pseudocholinesterase deficiency increasing action of succinylcholine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most likely reason which led to this scenario is<strong> phase II&nbsp;blockade </strong>produced by <strong>succinylcholine.</strong></p>\n<p>Phase II block is clinically seen with the dose <strong>&gt;5 mg/kg.&nbsp;</strong>It is&nbsp;seen with a&nbsp;single <strong>large</strong> dose, <strong>repeated</strong> doses, or a <strong>continuous</strong> infusion of <strong>Sch</strong> which can lead to <strong>desensitization</strong> of the receptors resulting in a <strong>prolonged</strong> neuromuscular <strong>blockade.</strong></p>\n<p>Causes of prolonged apnea include:</p>\n<ul>\n<li>Atypical/pseudocholinesterase deficiency - can result in apnea even with a normal dose of succinylcholine</li>\n<li>Altered response of endplate to depolarizing relaxant (myasthenia gravis)</li>\n<li>Accumulation of succinylcholine leading to phase II blockade</li>\n</ul>\n<p>Note: Although options A, B, and D can lead to prolonged apnea, in the above case scenario, the patient has received ~9 mg/kg of succinylcholine. Hence, the most probable diagnosis is phase II blockade leading to prolonged apnea.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3026",
      "difficulty": "medium"
    },
    {
      "text": "The anesthetist asks you to administer succinylcholine to a patient in the OT and warns you to monitor the dose carefully to prevent the development of a phase II block. Which of the following is incorrect regarding this phase of the block?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of fade phenomenon"
        },
        {
          "id": 2,
          "text": "Presence of post  tetanic facilitation"
        },
        {
          "id": 3,
          "text": "Preceded by muscle fasciculation"
        },
        {
          "id": 4,
          "text": "Can be reversed by cholinesterase inhibitor"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Phase I</strong> depolarizing block is <strong>preceded</strong> by<strong> muscle fasciculation</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Phase I</strong></td>\n<td><strong>Phase II</strong></td>\n</tr>\n<tr>\n<td>Depolarizing block</td>\n<td>Non-depolarizing block</td>\n</tr>\n<tr>\n<td>\n<p>No fade during repetitive stimulation </p>\n</td>\n<td>\n<p><strong>Fade</strong> during repetitive stimulation (tetanic or Train Of Four)</p>\n</td>\n</tr>\n<tr>\n<td>No post-tetanic facilitation</td>\n<td>\n<p><strong>Post tetanic facilitation</strong> (potentiation)</p>\n</td>\n</tr>\n<tr>\n<td>Block antagonized by rapid <strong>hydrolysis</strong> due to <strong>butyrylcholinesterase/plasma cholinesterase</strong> </td>\n<td>Block can be antagonized by administering a <strong>cholinesterase inhibitor</strong> like neostigmine.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<p><strong>Note</strong>: Cholinesterase inhibitors are not routinely used to reverse phase II blockade as certain individuals have <strong data-stringify-type=\"bold\">abnormal cholinesterase activity </strong>(due to genotypic variations). Their response to cholinesterase activity is unpredictable. Thus a <strong data-stringify-type=\"bold\">wait and watch</strong> policy is implemented where the patient is put on a <strong data-stringify-type=\"bold\">ventilator</strong> (100% O2) and observed for <strong data-stringify-type=\"bold\">24-48 hours</strong> until spontaneous reversal.<span class=\"c-message__edited_label\" dir=\"ltr\" data-sk=\"tooltip_parent\"> </span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3079",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following skeletal muscle relaxants exhibit the following response to the 'train of four protocol' used in the clinical assessment of neuromuscular blockade?",
      "choices": [
        {
          "id": 1,
          "text": "d-Tubocurarine"
        },
        {
          "id": 2,
          "text": "Mivacurium"
        },
        {
          "id": 3,
          "text": "Succinylcholine"
        },
        {
          "id": 4,
          "text": "Atracurium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Succinylcholine</strong> exhibits the above-given response to the <strong>'train of four</strong> <strong>protocol</strong>' used in the clinical assessment of <strong>neuromuscular blockade.</strong></p>\n<p>Train of four protocol is one of the methods used in the clinical assessment of neuromuscular blockade. It is done by stimulating the<strong> ulnar nerve</strong> with a stimulus and watching the contractile responses in the <strong>adductor pollicis</strong> muscle. Four successive stimuli of 2Hz strength are given at fixed time intervals and the response achieved is plotted as a graph.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d82ec65887b446d18af0026ea5495ad1x1280x1199.JPEG\" alt=\"Explanation Image\"><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Non-depolarizing blockers</strong></td>\n<td><strong>Depolarizing blockers</strong></td>\n</tr>\n<tr>\n<td><strong>Fade phenomenon&nbsp;</strong></td>\n<td>Present&nbsp;</td>\n<td>\n<p>Phase 1: Absent</p>\n<p>Phase 2: Present&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td>\n<p>Initial stimulus: Amount of Ach released is large enough to compete with the drug at the motor endplate causing maximal contraction of the muscle.</p>\n<p>Successive stimuli: Amount of Ach released is insufficient to compete with the drug and results in sequentially diminished contractions</p>\n</td>\n<td>\n<p>Phase 1: No competition between Sch and Ach. Sch acts like Ach at its receptors, but is not as easily metabolized by acetylcholinesterases resulting in persistent depolarisation.&nbsp;</p>\n<p>Phase 2: When the dose of Sch is increased maximally, it also exhibits a fade phenomenon.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a7866de0a3b64293bf3ddd0c1c1e3f2a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0587",
      "difficulty": "easy"
    },
    {
      "text": "Which drug stimulates the autonomic ganglia?",
      "choices": [
        {
          "id": 1,
          "text": "D-tubocurarine"
        },
        {
          "id": 2,
          "text": "Succinylcholine"
        },
        {
          "id": 3,
          "text": "Pancuronium"
        },
        {
          "id": 4,
          "text": "Vecuronium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Succinylcholine</strong> stimulates the autonomic ganglia.&nbsp;</p>\n<ul>\n<li><strong>Parasympathetic</strong> ganglion (vagal ganglion) -&nbsp;bradycardia</li>\n<li><strong>Sympathetic</strong> ganglion - hypertension and tachycardia.</li>\n</ul>\n<p>Pancuronium causes tachycardia by blocking the cardiac muscarinic receptor and not by stimulation of autonomic ganglia.</p>\n<p>D-tubocurarine blocks the autonomic ganglia. Whereas vercuronium does not act on autonomic ganglia.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3028",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following muscle relaxants does not require the administration of a block reversal agent following surgery?",
      "choices": [
        {
          "id": 1,
          "text": "Succinylcholine"
        },
        {
          "id": 2,
          "text": "Pancuronium"
        },
        {
          "id": 3,
          "text": "Rocuronium"
        },
        {
          "id": 4,
          "text": "Vecuronium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Reversal</strong> of neuromuscular blockade is usually <strong>not needed</strong> in cases where&nbsp;<strong>succinylcholine</strong>&nbsp;is used, as it is rapidly metabolized by pseudocholinesterase resulting in a <strong>short duration of action</strong>.</p>\n<p>Cholinesterase inhibitors can prolong neuromuscular blockade produced by succinylcholine&nbsp;by increasing neuromuscular junction ACh concentration and inhibiting the pseudocholinesterase-induced metabolism of succinylcholine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3058",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following adverse effects are not attributed to succinylcholine?",
      "choices": [
        {
          "id": 1,
          "text": "Hypokalemia"
        },
        {
          "id": 2,
          "text": "Masseter spasm"
        },
        {
          "id": 3,
          "text": "Increased intracranial pressure"
        },
        {
          "id": 4,
          "text": "Arrhythmias"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Succinyl choline</strong> produces <strong>hyperkalemia</strong>&nbsp;not hypokalemia.</p>\n<p>Use of succinylcholine&nbsp;<strong>increases</strong> the plasma<strong> K+ levels </strong>by<strong> 0.5 mEq/L.</strong> This increase in K+ is well tolerated by healthy individuals but could be deliterious in patients with severe metabolic acidosis and hypovolemia.</p><hr><h3>Related Pearl: Side effects of succinyl choline</h3><p><strong>The following are the side effects of succinyl choline:</strong></p>\n<ul>\n<li>Cardiovascular effects:\n<ul>\n<li>Sinus bradycardia</li>\n<li>Junctional rhythms</li>\n<li>Ventricular dysrhythmias</li>\n</ul>\n</li>\n<li>Hyperkalemia</li>\n<li>Myalgia</li>\n<li>Masseter spasm: Succinyl choline can trigger malignant hyperthermia</li>\n<li>Increased intracranial pressure:&nbsp;Succinylcholine may lead to an activation of the EEG and slight increases in CBF&nbsp;and ICP in some patients.</li>\n<li>Increased intraocular pressure</li>\n<li>Increased intragastric pressure</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3013",
      "difficulty": "easy"
    },
    {
      "text": "While inducing anesthesia, you noticed the patient's eyelids were twitching. A few hours post-op, she complains of generalized body ache. Which muscle relaxant was likely administered to her?",
      "choices": [
        {
          "id": 1,
          "text": "Atracurium"
        },
        {
          "id": 2,
          "text": "Mivacurium"
        },
        {
          "id": 3,
          "text": "Suxamethonium"
        },
        {
          "id": 4,
          "text": "Pancuronium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The muscle relaxant administered was likely<strong>&nbsp;suxamethonium </strong>(succinylcholine). It is associated with <strong>muscle fasciculations</strong> and <strong>myalgia</strong>.</p>\n<p>Administration of a non-depolarizing muscle relaxant like rocuronium prior to succinylcholine (<strong>precurarization</strong>) is effective in <strong>prevent</strong>ing fasciculations and reducing postoperative myalgias.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3020",
      "difficulty": "easy"
    },
    {
      "text": "You are about to administer succinylcholine to a patient before intubating him when your senior asks you to administer a non-depolarizing muscle relaxant before doing so. He says this will prevent muscle fasciculations. Which drug do you choose for this?",
      "choices": [
        {
          "id": 1,
          "text": "Pancuronium"
        },
        {
          "id": 2,
          "text": "Atracurium"
        },
        {
          "id": 3,
          "text": "Rocuronium"
        },
        {
          "id": 4,
          "text": "Vecuronium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Rocuronium</strong> is the agent of choice for <strong>precurarization</strong>.</p>\n<p>Precurarization&nbsp;is the administration of a small dose (10% of ED95) of a&nbsp;<strong>non-depolarizing neuromuscular blocking agent,</strong>&nbsp;a few minutes before succinylcholine to <strong>minimize</strong>&nbsp;<strong>complications</strong>&nbsp;like fasciculations, postoperative myalgia, and rise in intragastric, intraocular, and intracranial pressure.</p>\n<p>Rocuronium is <strong>ideal</strong> because it has a <strong>rapid onset of action</strong> (90 seconds), which is comparable with succinylcholine and is very effective in decreasing fasciculations and postoperative myalgias.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3055",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following patients are not at risk of hyperkalemia from succinylcholine?",
      "choices": [
        {
          "id": 1,
          "text": "Patient of muscle dystrophy"
        },
        {
          "id": 2,
          "text": "Patient with 45% burns"
        },
        {
          "id": 3,
          "text": "Patient of spinal cord injury"
        },
        {
          "id": 4,
          "text": "Patient of myasthenia gravis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>All the given conditions except myasthenia gravis are associated with the risk of hyperkalemia from succinylcholine (SCh)&nbsp;</p>\n<p>In patients with&nbsp;<strong>myasthenia gravis:&nbsp;</strong></p>\n<ul>\n<li><strong>Depolarizing</strong> muscle <strong>relaxants</strong> (SCh) - resistant&nbsp;</li>\n<li><strong>Non-depolarizing</strong> muscle relaxants - hypersensitive&nbsp;</li>\n</ul>\n<p>All the other options include conditions that can have preexisting hyperkalemia. Thus, the <strong>succinylcholine-induced release</strong> of <strong>potassium</strong> from skeletal muscles may lead to <strong>catastrophic hyperkalemia</strong> in these patients.</p><hr><h3>Related Pearl: Conditions causing susceptibility to succinylcholine-induced hyperkalemia</h3><p>The conditions that predispose to hyperkalemia following succinylcholine administration are:</p>\n<ul>\n<li>Burn injury</li>\n<li>Massive trauma, head and spinal cord injury</li>\n<li>Severe intra-abdominal infection</li>\n<li>Encephalitis, tetanus and stroke</li>\n<li>Neuropathy like Guillain-Barre syndrome</li>\n<li>Severe Parkinson&rsquo;s disease</li>\n<li>Prolonged total body immobilization</li>\n<li>Hemorrhagic shock with metabolic acidosis</li>\n<li>Myopathies (eg, Duchenne&rsquo;s dystrophy)</li>\n</ul>\n<p>So, the use of succinylcholine is relatively contraindicated in patients having these conditions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2987",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following adverse effects would you not expect while using succinylcholine as a muscle relaxant for a surgery being done under general anesthesia?",
      "choices": [
        {
          "id": 1,
          "text": "Increased intra ocular pressure"
        },
        {
          "id": 2,
          "text": "Increased intra cranial pressure"
        },
        {
          "id": 3,
          "text": "Hyperkalemia"
        },
        {
          "id": 4,
          "text": "Decreased intragastric pressure"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Succinylcholine <strong>increases intragastric pressure. </strong>This is likely due to fasciculations of the abdominal skeletal muscle.</p><hr><h3>Related Pearl: Side effects of succinyl choline</h3><p><strong>The following are the side effects of succinyl choline:</strong></p>\n<ul>\n<li>Cardiovascular effects:\n<ul>\n<li>Sinus bradycardia</li>\n<li>Junctional rhythms</li>\n<li>Ventricular dysrhythmias</li>\n</ul>\n</li>\n<li>Hyperkalemia</li>\n<li>Myalgia</li>\n<li>Masseter spasm: Succinyl choline can trigger malignant hyperthermia</li>\n<li>Increased intracranial pressure:&nbsp;Succinylcholine may lead to an activation of the EEG and slight increases in CBF&nbsp;and ICP in some patients.</li>\n<li>Increased intraocular pressure</li>\n<li>Increased intragastric pressure</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3014",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions does not reduce the activity of butyrylcholinesterase?",
      "choices": [
        {
          "id": 1,
          "text": "Liver disease"
        },
        {
          "id": 2,
          "text": "Pregnancy"
        },
        {
          "id": 3,
          "text": "Malnutrition"
        },
        {
          "id": 4,
          "text": "Renal disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>renal disease</strong> does <strong>not affect</strong> the activity of <strong>butyrylcholinesterase.</strong></p>\n<p>Butyrylcholinesterase is the enzyme that <strong>degrades succinylcholine.</strong> It is <strong>synthesized</strong> in the <strong>liver</strong> and found in the plasma.</p>\n<p>Reduced butyrylcholinesterase activity is seen in:</p>\n<ul>\n<li>Liver disease</li>\n<li>Pregnancy</li>\n<li>Malnutrition</li>\n<li>Old age</li>\n<li>Drugs like - oral contraceptives, monoamine oxidase inhibitors, echothiophate, cytotoxic drugs,&nbsp; anticholinesterase drugs, and metoclopramide.</li>\n</ul>\n<p>Decreased butyrylcholinesterase is not a major concern in clinical practice because even a large decrease in the enzyme activity will produce only a slight increase in the duration of neuromuscular blockade.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3016",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs potentiate the action of succinylcholine?<div class='question-desc-html'><ol>\n<li>Neostigmine</li>\n<li>Oral contraceptive pills</li>\n<li>Metoclopramide</li>\n<li>Streptomycin</li>\n<li>Calcium gluconate&nbsp;</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 3, 5"
        },
        {
          "id": 3,
          "text": "1, 2, 4"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Calcium</strong> causes <strong>resistance</strong> to neuromuscular <strong>blockade</strong>&nbsp;caused by succinylcholine.&nbsp;</p>\n<p>Neostigmine being an <strong>anticholinesterase</strong> leads to inhibition of acetylcholinesterase. This results in a <strong>higher ACh concentration</strong> at the nerve terminal, which intensifies depolarization.</p>\n<p><strong>Neostigmine,</strong> oral contraceptive pills <strong>(OCPs), metoclopramide,</strong> and<strong>&nbsp;aminoglycosides</strong> (streptomycin) can <strong>potentiate</strong> the <strong>paralysis</strong> produced by succinylcholine.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3017",
      "difficulty": "medium"
    },
    {
      "text": "What is the next line of management in a patient diagnosed with succinylcholine apnoea?",
      "choices": [
        {
          "id": 1,
          "text": "Increase the dose of succinylcholine"
        },
        {
          "id": 2,
          "text": "Administer neostigmine"
        },
        {
          "id": 3,
          "text": "Fresh frozen plasma transfusion"
        },
        {
          "id": 4,
          "text": "Continue mechanical ventilation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The mainstay in the treatment of <strong>succinylcholine apnea</strong> due to atypical pseudocholinesterase is to&nbsp;<strong>continue mechanical ventilation </strong>until&nbsp;muscle function returns to normal by clinical signs.</p>\n<p>Option B: Administration of <strong>neostigmine</strong> is <strong>controversial</strong> as the effects may be transient, possibly followed by an intensified neuromuscular blockade.</p>\n<p>Option C: Fresh frozen plasma can augment the patient's endogenous plasma pseudocholinesterase activity but is not recommended because of the risk of iatrogenic viral infections.</p>\n<p>Note: If&nbsp;<strong>human plasma cholinesterase</strong>&nbsp;is available, it can be given to <strong>reverse neuromuscular blockade</strong>.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3023",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old child was given intravenous succinylcholine for rapid sequence intubation at a dose of 0.5 mg/kg. During intubation, a masseteric spasm was noted. Temperature and BP were normal. What would be your first line of management?",
      "choices": [
        {
          "id": 1,
          "text": "IV dantrolene"
        },
        {
          "id": 2,
          "text": "Cool the child by using cooling blanket"
        },
        {
          "id": 3,
          "text": "Stop intubation"
        },
        {
          "id": 4,
          "text": "Increase the dose of succinylcholine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The first line of management in this child would be to <strong>increase</strong> the<strong> dose</strong> of<strong> succinylcholine</strong>.</p>\n<p>The incidence of <strong>muscle spasms without</strong> any symptoms and signs of <strong>malignant hyperthermia</strong> frequently results from an <strong>inadequate</strong> <strong>dosage</strong> of succinylcholine. Succinylcholine dosage for intubation is&nbsp;<strong>1-2mg/kg</strong></p>\n<p>Conditions to be ruled out in isolated masseteric spasm:</p>\n<ul>\n<li><strong>Inadequate dose</strong> of succinylcholine (less than the recommended dose of 1 mg/kg)</li>\n<li><strong>Inadequate time</strong> for the onset of succinylcholine action</li>\n<li>Duchenne muscular dystrophy, myotonia congenita, and other <strong>muscle disorders</strong></li>\n<li>Temporomandibular joint dislocation</li>\n</ul>\n<p>Confusion-buster: Although an increase in the <strong>tone</strong> of the <strong>masseter</strong>&nbsp;is considered to be an <strong>early indicator</strong> of <strong>malignant hyperthermia,</strong> this finding is <strong>not consistently</strong> associated with it.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3025",
      "difficulty": "hard"
    },
    {
      "text": "During a pre-op evaluation, a patient tells you he had been kept on a ventilator for 2 days following his previous surgery. There are similar instances in his family history. The reports from his previous surgery reveal his dibucaine number to be 20. What is this number used to assess?",
      "choices": [
        {
          "id": 1,
          "text": "Concentration of butyrylcholinesterase"
        },
        {
          "id": 2,
          "text": "Concentration of acetyl cholinesterase"
        },
        {
          "id": 3,
          "text": "Genetic make up of an individual with respect to butyryl cholinesterase"
        },
        {
          "id": 4,
          "text": "Concentration of ACh receptors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Dibucaine number</strong> indicates the <strong>genetic makeup </strong>of an individual with respect to<strong> butyrylcholinesterase. </strong>It is a qualitative measure that measures<strong> pseudocholinesterase function</strong> but not the amount of enzyme.</p>\n<p>A patient with <strong>normal </strong>pseudocholinesterase has a <strong>dibucaine number</strong> of<strong> 80</strong>; whereas a homozygote for an atypical enzyme will have a dibucaine number of 20.</p>\n<p>Therefore, the adequacy of pseudocholinesterase can be determined quantitatively in units per liter - in the&nbsp;laboratory</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3021",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with a Dibucaine number of 20, which of the following drug/s are to be avoided?<div class='question-desc-html'><ol>\n<li>Succinylcholine</li>\n<li>Pancuronium</li>\n<li>Atracurium</li>\n<li>Mivacurium</li>\n<li>Vecuronium</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "Only 1"
        },
        {
          "id": 2,
          "text": "1, 2 & 5"
        },
        {
          "id": 3,
          "text": "1 & 4"
        },
        {
          "id": 4,
          "text": "1, 2 & 3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Succinylcholine</strong> and <strong>mivacurium</strong> are eliminated through hydrolysis by <strong>plasma cholinesterases</strong>. Thus, in a patient with a <strong>low Dibucaine number,</strong> both of these drugs should be <strong>avoided.&nbsp;</strong>Both drugs can cause prolonged apnea in patients with&nbsp;atypical plasma cholinesterase.&nbsp;</p>\n<p>Dibucaine number&nbsp;refers to the<strong>&nbsp;percentage</strong> of<strong> inhibition</strong> of<strong> pseudocholinesterase</strong>&nbsp;activity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0450",
      "difficulty": "hard"
    },
    {
      "text": "Which selective GABA-B receptor agonist is used as a muscle relaxant?",
      "choices": [
        {
          "id": 1,
          "text": "Diazepam"
        },
        {
          "id": 2,
          "text": "Clonazepam"
        },
        {
          "id": 3,
          "text": "Flumazenil"
        },
        {
          "id": 4,
          "text": "Baclofen"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Baclofen</strong> is a centrally acting&nbsp;<strong>selective GABA-B receptor agonist</strong> used as a <strong>muscle relaxant</strong>.&nbsp;It hyperpolarizes neurons by increasing potassium conductance and altering calcium influx.&nbsp;</p>\n<div class=\"page\" title=\"Page 373\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 374\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Centrally acting muscle relaxants reduce skeletal muscle tone by a selective action in the cerebrospinal axis without altering consciousness.</p>\n<p>Classification of centrally acting muscle relaxants:</p>\n<div class=\"column\">\n<ul>\n<li><strong>Mephenesin congeners</strong> - mephenesin, carisoprodol, chlorzoxazone, chlormezanone, methocarbamol.</li>\n<li><strong>Benzodiazepines</strong> - diazepam and others.</li>\n<li><strong>GABA mimetic</strong> - baclofen, thiocolchicoside.</li>\n<li><strong>Central &alpha;2 receptor agonist</strong> - tizanidine.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0446",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following muscle relaxants decreases calcium release from sarcoplasmic reticulum?",
      "choices": [
        {
          "id": 1,
          "text": "Succinylcholine"
        },
        {
          "id": 2,
          "text": "Dantrolene"
        },
        {
          "id": 3,
          "text": "Vecuronium"
        },
        {
          "id": 4,
          "text": "Decamethonium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Calcium release</strong> from the sarcoplasmic reticulum is <strong>decreased</strong> by&nbsp;<strong>dantrolene</strong>.</p>\n<p>It is a <strong>direct-acting</strong> skeletal muscle <strong>relaxant</strong> that acts on the <strong>RyR1</strong> (ryanodine receptor) calcium channels in the sarcoplasmic reticulum of skeletal muscles and <strong>inhibits calcium-induced calcium release</strong>. It results in the&nbsp;uncoupling of membrane depolarization and muscle contraction.</p>\n<p>IV dantrolene is the drug of<strong> choice</strong> for <strong>malignant hyperthermia</strong> which is due to the persistent release of calcium from the sarcoplasmic reticulum.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0447",
      "difficulty": "medium"
    },
    {
      "text": "You are planning to administer a non-depolarising muscle relaxant to a patient. Which of the following will you not choose?",
      "choices": [
        {
          "id": 1,
          "text": "Pancuronium"
        },
        {
          "id": 2,
          "text": "Rocuronium"
        },
        {
          "id": 3,
          "text": "Suxamethonium"
        },
        {
          "id": 4,
          "text": "Vecuronium"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Suxamethonium or <strong>succinyl choline</strong> is a <strong>depolarizing</strong> muscle relaxant. All the other options are non-depolarising muscle relaxants and so can be chosen here.</p><hr><h3>Related Pearl: Types of muscle relaxants</h3><p>There are 2 types of muscle relaxants: depolarizing and non-depolarizing.</p>\n<p><strong>Depolarizing</strong> Muscle Relaxant-<strong>&nbsp;Succinylcholine</strong></p>\n<p><strong>Non-Depolarizing</strong> Muscle Relaxants:</p>\n<ul>\n<li><strong>Ultra short-</strong>acting (&lt;10 minutes) - Gantacurium</li>\n<li><strong>Short</strong>-acting (10-20 minutes) -&nbsp;Mivacurium</li>\n<li><strong>Intermediate-</strong>acting (20-50 minutes)\n<ul>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Vecuronium</li>\n<li>Rocuronium</li>\n</ul>\n</li>\n<li><strong>Long-</strong>acting (&gt;50 minutes)\n<ul>\n<li>Pancuronium</li>\n<li>Doxacurium</li>\n<li>Pipecuronium</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2977",
      "difficulty": "easy"
    },
    {
      "text": "A 72-year-old man with a history of a stroke 8 years prior presents with a displaced humerus fracture. He is planned for open reduction and fixation. Which muscle relaxant is to be avoided in him?",
      "choices": [
        {
          "id": 1,
          "text": "Succinylcholine"
        },
        {
          "id": 2,
          "text": "Atracurium"
        },
        {
          "id": 3,
          "text": "Mivacurium"
        },
        {
          "id": 4,
          "text": "Cisatracurium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Succinylcholine is <strong>avoided</strong> in patients with a history of <strong>stroke,</strong> due to the risk of<strong> hyperkalemia.</strong></p><hr><h3>Related Pearl: Conditions causing susceptibility to succinylcholine-induced hyperkalemia</h3><p>The conditions that predispose to hyperkalemia following succinylcholine administration are:</p>\n<ul>\n<li>Burn injury</li>\n<li>Massive trauma, head and spinal cord injury</li>\n<li>Severe intra-abdominal infection</li>\n<li>Encephalitis, tetanus and stroke</li>\n<li>Neuropathy like Guillain-Barre syndrome</li>\n<li>Severe Parkinson&rsquo;s disease</li>\n<li>Prolonged total body immobilization</li>\n<li>Hemorrhagic shock with metabolic acidosis</li>\n<li>Myopathies (eg, Duchenne&rsquo;s dystrophy)</li>\n</ul>\n<p>So, the use of succinylcholine is relatively contraindicated in patients having these conditions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3012",
      "difficulty": "easy"
    }
  ]
}